Conditions: Breast Cancer; Pancreas Cancer; Prostate Cancer; Lung Cancer; Colon Cancer; Esophagus Cancer; Liver Cancer; Ovary Cancer; Lymphoma
Intervention: Drug: NP-G2-044
Sponsors: Novita Pharmaceuticals, Inc.; Translational Drug Development
Not yet recruiting - verified June 2017
http://ift.tt/2tiPivK
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου